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ABSTRACT
CHARACTERIZATION OF THE RECONSTITUTED AND NATIVE
PSEUDOMONAS AERUGINOSA TYPE III SECRETION SYSTEM
TRANSLOCON
SEPTEMBER 2015
KATHRYN MONOPOLI
B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Alejandro P. Heuck

The Type III Secretion (T3S) system is a system utilized by many
pathogenic bacteria to inject proteins into host cells during an infection. Effector
proteins enter the host cell by passing through the proteinaceous T3S translocon,
which forms a pore on the host cell membrane. Pseudomonas aeruginosa is an
opportunistic pathogen that utilizes the T3S system, and very little is known
about how the P. aeruginosa translocon forms.
The proteins PopB and PopD are believed to assemble into the P.
aeruginosa translocon. A pore-forming heterocomplex of PopB and PopD has
been reconstituted in model membranes, however this heterocomplex has not
been assessed in its relation to the translocon formed on the host cell. The
interaction of this heterocomplex with other T3S system components was
measured to determine if this complex acts similarly to the translocon. Initial
assays that can be used to compare the molecular weight of the translocon
isolated from eukaryotic cells after P. aeruginosa contact to the calculated
molecular weight of the heterocomplex were developed as well. This study
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provides insight into how the PopB:PopD heterocomplex formed in model
membranes relates to the translocon formed during a P. aeruginosa infection.
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CHAPTER 1
INTRODUCTION
1.1 Pseudomonas aeruginosa
Pseudomonas aeruginosa is a ubiquitous Gram-negative opportunistic
pathogen that is one of the leading causes of nosocomial infections (Vincent,
2003). This bacterium colonizes a wide variety of niches including soil, plants,
and animals. In humans, P. aeruginosa is found as a part of the skin flora (Cogen
et al., 2008), however it commonly colonizes the respiratory, urinary, and
gastrointestinal tracts causing severe infections in immunocompromised patients
(Carmeli, 1999).
P. aeruginosa is the leading cause of infections in patients with chronic
obstructive pulmonary disease, cystic fibrosis, and burns, as well as the number
one cause of ventilator associated pneumonia; the latter two having mortality
rates greater than 30% (Vincent, 2003; Oliver et al., 2008). Infections are difficult
to treat as P. aeruginosa easily acquires antibiotic resistance (Tenover, 2006).
Furthermore, this pathogen forms biofilms, which can allow development of
antibiotic resistance up to 1,000 times that of planktonic cells (Hoyle and
Costerton, 1991). In fact, biofilms occur in approximately 65% of all human P.
aeruginosa infections (Filloux and Vallet, 2003; Chicurel, 2000).
Like other gram-negative pathogens, this bacterium uses the Type III
Secretion (T3S) system to inject toxins into a host cell. The T3S system is closely
tied with infection; in fact, immunization with T3S components successfully
protects animals from P. aeruginosa pneumonia (Lyzak et al., 2000). This system

1

is common to many pathogenic bacteria including: Chlamydia species, Shigella
species, Salmonella species, and Yersinia species (Coburn et al., 2007), and a
greater understanding of this infection mechanism is necessary to develop
effective infection therapies.
1.2 Type III Secretion system
The T3S system is used to inject toxins directly into the host cell
cytoplasm. This system utilizes a syringe-like T3S apparatus. The T3S apparatus
consists of an injectisome that spans both the inner and outer bacterial cell
membranes, a needle that extends outward from the cell surface, and a protein
oligomer that forms at the tip of the needle (Fig 1.1). Additionally, translocator
proteins function to form a pore in the host cell membrane to allow effector
proteins to pass into the host cell.
Type III Secretion remains inactive until the bacterium comes in contact
with a host cell (Mueller, 2005; Matteï et al., 2011). The T3S apparatus is present
at the bacterial cell surface, and contact between the needle tip and the host cell
is hypothesized to activate Type III Secretion. Upon T3S activation, translocators
are first translocated through the needle in a partially folded state, and assemble
on the target membrane forming the translocon. The translocon is then believed
to engage with the needle tip, allowing for efficient transport of effectors from the
bacterial cytosol into the host cell cytosol (Fig 1.2).
1.3 Injectisome
The injectisome is a complex of proteins that spans the inner and outer
membrane of the bacteria (Fig 1.1). The T3S system injectisome closely
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Figure 1.1. Ysc Family Type III Secretion Apparatus. P. aeruginosa utilizes
the Ysc family T3S apparatus (Cornelis, 2006), which consists of an injectisome
spanning the inner and outer bacterial membranes, a 50-80 nm needle that
extends beyond the cell surface capped by a tip complex that interacts with the
host cell membrane. Translocator protein effector proteins are secreted through
this apparatus during an infection.
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Figure 1.2. Translocon Hypothesis in P. aeruginosa T3S apparatus.
Interaction with a host cell stimulates T3S and the translocators PopB (blue) and
PopD (red), to be released from their chaperone PcrH (green) in the bacterial
cytoplasm and be secreted through the needle in a partially unfolded state. The
translocators insert into the host cell membrane and assemble into the
translocon. The needle engages with the host cell membrane through the tip
complex, PcrV (orange). Effectors (black) are secreted through the T3S
apparatus and enter the host cell through the translocon pore.

4

resembles the flagellum (Cornelis, 2006). Based on cryo-EM of purified
Salmonella T3S apparatuses, the injectisome consists of two rings anchored in
the bacterial membranes with a hollow channel (~2 nm in diameter) traversing its
length (Schraidt and Marlovitz, 2011). An ATPase component of the injectisome
likely aids in unfolding secreted proteins to enable passage through the narrow
channel (Akeda and Galán, 2005). The T3S needle extends from the injectisome,
continuing the hollow channel that effectors pass through.
1.4 Needle
The T3S needle is an oligomer made up of repeating subunits of a small
needle protein (PscF in P. aeruginosa) (Pastor et al., 2005). The T3S needle
length is fixed within a species. In P. aeruginosa the needle is approximately 50
nm, with an outer and inner diameter of 8 and 2 nm respectively (Pastor et al.,
2005). While P. aeruginosa needles have been isolated, their structure has not
been well studied. Needles purified from Shigella showed that the needle protein
oligomerizes into a helical structure with a 24 Å pitch with approximately 5.6
subunits per turn (Cordes et al., 2003). The needle is capped by a proteinaceous
tip complex. PcrV forms the P. aeruginosa T3S needle tip complex (Mueller et
al., 2005).
1.5 Translocators
While the injectisome and needle are sufficient to secrete effector proteins
out of the bacterium, effectors need to translocate across the plasma membrane
of the target cell. In P. aeruginosa, two proteins (PopB and PopD) secreted by
the T3S system are required for translocation of effectors into the host cell
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(Dacheux et al., 2001; Sundin et al; 2004; Gouer et al., 2004). These
translocators form pores in model membranes (Schoen et al., 2003; Faudry et
al., 2006; Romano et al., 2011), and are found on host cell membranes after
contact with P. aeruginosa (Goure et al., 2004), supporting the hypothesis that
these translocators assemble into the translocon.
PopB is the major translocator with a molecular weight of 40.3 kDa
(Hauser et al., 1998). PopD is the minor translocator with a molecular weight of
31.3 kDa. The structures of PopB and PopD are not well characterized because
these proteins have been difficult to crystalize due to their hydrophobicity. A more
in-depth characterization of these proteins is necessary to understand how they
interact with membranes.
It is hypothesized that the translocator proteins form the translocon
spontaneously. This is an uncommon mechanism for membrane protein
insertion, as most membrane proteins are inserted by complex cellular machinery
involving the ribosome and chaperones (Cymer et al., 2014). The ability for these
proteins to assemble on membranes spontaneously facilitates their study in
model membranes. PopB and PopD translocator complexes can be reconstituted
in liposomes (Romano et al., 2011).
These P. aeruginosa translocator proteins are important for infection of the
host cell, and very little is known about how they assemble on the host cell
membrane. Therefore it is important to study how PopB and PopD interact with
the host cell to better understand how effectors are translocated in the T3S
system.
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1.6 Reconstituting translocators in membranes
PopB and PopD assemble on model membranes, forming pores
individually as well as in complex (Romano et al., 2011; Schoen et al., 2003;
Faudry et al., 2006). When incubated together, PopB and PopD form a
heterocomplex of eight PopB and eight PopD (Romano et al., 2011). This
complex is of particular interest because when in the complex, the pore formation
and membrane insertion of PopD is enhanced (Romano et al., 2011; Monopoli,
2014). Formation of this complex in model membranes is irreversible (Monopoli,
2014).
To maximize heterocomplex assembly, translocators must be added
simultaneously to model membranes (Monopoli, 2014). Heterocomplex assembly
in model membranes is optimized at mildly acidic pH (Romano et al., 2011),
however the heterocomplex remains inserted in membranes upon neutralizing
the pH (Monopoli, 2014). This allows for study of this complex at neutral pH,
allowing for study of this complex in relation to other proteins.
It is not known how the heterocomplex reconstituted in model membranes
relates to the translocon inserted in host cells. Here the heterocomplex is studied
to determine if it is functional for interaction with other components of the T3S
system (specifically: P. aeruginosa and the T3S needle). Assessment of these
interactions will provide insight into the relationship between the heterocomplex
reconstituted in model membranes and the translocon formed in host cell
membranes during P. aeruginosa infection.
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CHAPTER 2
INTERACTION OF MEMBRANE-RECONSTITUTED TRANSLOCATORS
WITH ISOLATED P. AERUGINOSA T3S COMPONENTS
2.1 Introduction
We have shown that the P. aeruginosa translocators PopB and PopD
assemble a heterocomplex in model membranes (Romano et al., 2011), however
this heterocomplex has not been assessed in relation to its interaction with the
rest of the T3S system. One way to evaluate this is to determine if other
components of the P. aeruginosa T3S system, that are predicted to interact with
the translocon, interact with the reconstituted complexes. One of these
components is the tip complex. The tip complex is believed to be composed of
the protein PcrV, and located at the tip of the needle formed by the protein PscF
(Mueller et al., 2005; Pastor et al., 2005). To assess their ability to interact with
the heterocomplex, we purified recombinant PcrV protein and initiated attempts
to purify needles formed by P. aeruginosa.
2.2 Experimental design
Translocator heterocomplexes were reconstituted in model membranes by
diluting a premixed solution of PopB and PopD in 6 M urea, into buffer containing
liposomes (see Methods 2.5.1) (Romano et al., 2011). This was performed at
mildly acidic pH (pH 4.3) to maximize binding and insertion of translocators
(Faudry et al., 2006; Romano et al., 2011). The pH was neutralized before
adding other T3S components. Previous studies indicate that the heterocomplex,
when inserted at pH 4.3, remains stably inserted in membranes upon pH
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neutralization (Monopoli, 2014) (Fig 2.1). After incubating with the T3S
components, a flotation assay was performed to isolate the membranes (see
Methods 2.5.2). Components that bound to the heterocomplexes would be
present in the membrane fraction isolated from the flotation assay. As a control,
the binding of the added components to the liposomal membranes would be
evaluated by exactly the same procedure without adding the translocators.
2.3 Results
2.3.1 Purification of unmodified recombinant PcrV
The needle tip complex in the P. aeruginosa T3S system is believed to be
made up of PcrV (Mueller et al., 2005). It is hypothesized that PcrV interacts
directly with the translocon. Using the protocol outlined in 2.5.3, unmodified
recombinant PcrV was purified to approximate 88% homogeneity (C. Sanchez,
unpublished data) (Fig 2.2).
2.3.2 Interaction of monomeric PcrV with heterocomplex
The interaction of monomeric PcrV with the membrane-bound
translocators was measured using the assay described in 2.2. To control for
nonspecific binding of PcrV to membranes, PcrV was incubated with membranes
in the absence of the heterocomplex at neutral pH. Membrane-bound protein was
separated on an SDS-PAGE and the presence of PcrV was detected with a
western blot (Fig 2.3).
No binding of PcrV was seen after addition of monomeric PcrV (Fig 2.3).
The absence of binding indicated that oligomeric PcrV or other T3S factors may
be necessary for this interaction to occur. However, the addition of media
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Figure 2.1. PopB in heterocomplex remains bound to membranes after pH
neutralization. Heterocomplexes of PopBV191CBodipy and PopD were reconstituted
in membranes at pH 4 (lanes 1 and 2) and pH 7 (lane 3) (essentially as in 2.5.1).
The pH was neutralized to pH 7 with 2μ 2M Trizma, pH 9.0 (lane 2), or was
unchanged (lanes 1 and 3), before performing a flotation assay to isolate
membrane bound protein (see Methods 2.5.2). Samples were TCA precipitated
and separated on a 10% acrylamide SDS-PAGE. PopBV191CBodipy was detected
by scanning with a Typhoon FLA 7000 gel scanner exciting at 488 nm. A sample
containing the total amount of PopBV191CBodipy present was included as a
comparison (Total Protein). PopBV191CBodipy labeling efficiency was 55%.
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Figure 2.2. Purification of unmodified recombinant monomeric PcrV.
Unmodified recombinant monomeric PcrV was purified (see Methods 2.5.3). The
purified PcrV was separated on a 10% acrylamide SDS-PAGE and stained with
Coomassie (left) or transferred to a polyvinylidene fluoride (PVDF) membrane
and detected with polyclonal anti-PcrV antibodies (right). PcrV appears as the
dominant band in the gel stained with Coomassie (arrow). Molecular weights are
indicated, PcrV estimated molecular weight is 32 kDa.
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Figure 2.3. Monomeric PcrV does not bind heterocomplex. The translocator
heterocomplex was reconstituted in membranes (see Methods 2.5.1) and
incubated with monomeric PcrV. Membrane bound protein was isolated with a
flotation assay (see Methods 2.5.2), and TCA precipitated before separating on a
10% acrylamide SDS-PAGE and transferring to a PVDF membrane. PcrV was
detected with a polyclonal anti-PcrV antibody. Contents of the sample in each
lane are indicated at the bottom. A sample containing the total amount of PcrV
added was included as a comparison (Total Protein).
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containing other factors secreted by P. aeruginosa did not affect monomeric PcrV
binding (Fig 2.4). Purified oligomeric PcrV was not available, however we
evaluated the possibility of using needles that contain the oligomers at the tip.
T3S needles can be isolated from P. aeruginosa (Pastor et al., 2005; Gebus,
2008) as described below.
2.3.3 Purification of the T3S needle
Previous studies indicate that T3S needles from P. aeruginosa and other
bacteria can be sheared from the surface of the bacteria mechanically (Gebus,
2008; Blaylock et al., 2010; Hoiczyk and Blobel, 2001). These needles can be
further purified from other components using various methods. Two methods
were adapted for purification of T3S needles from P. aeruginosa (see Methods
2.5.4). The proteins isolated by the needle purification procedures were analyzed
initially by SDS-PAGE and Coomassie staining.
The needles are composed of the 9 kDa needle protein, PscF (Pastor et
al., 2005). Therefore the presence of a dominant band at 9 kDa on an SDSPAGE would denote the presence of needles. To resolve this lower molecular
weight protein, a Tricine SDS-PAGE was used instead of the traditional Laemmli
SDS-PAGE (see Methods 2.5.4.4). This method involves an alternative buffering
system that allows for complete separation of proteins smaller than 20 kDa
(Schägger and von Jagow, 1987). The Tricine SDS-PAGE provided satisfactory
resolution of protein below 10 kDa (Fig 2.5).
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Figure 2.4. Components secreted by P. aeruginosa do not enhance PcrV
binding to the heterocomplex. The translocator heterocomplex was
reconstituted in membranes (see Methods 2.5.1) and incubated with monomeric
PcrV along with growth media (2 μg protein). Growth media was obtained after
culturing P. aeruginosa cultured under T3S inducing conditions (see Methods
2.5.4.1) until an OD600 of 0.8 was reached. Membrane bound protein was
isolated with a flotation assay (see Methods 2.5.2), and TCA precipitated before
separating on a 10% acrylamide SDS-PAGE and transferring to a PVDF
membrane. PcrV was detected with polyclonal anti-PcrV antibodies. Contents of
the sample in each lane are indicated at the bottom (growth media and
membranes were present in both samples). A sample containing the total amount
of PcrV added was included as a comparison (Total Protein).
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Figure 2.5. Tricine SDS-PAGE is superior to Laemmli SDS-PAGE in
separating low molecular weight proteins. Partially purified P. aeruginosa T3S
needles purified from PA103 using Method A (see Methods 2.5.4.1), were
separated using (A) Tricine SDS-PAGE (see Methods 2.5.4.4) or (B) Laemmli
SDS-PAGE and stained with Coomassie. Both gels contained 15% acrylamide.
Molecular weights are indicated. The predicted molecular weight of the needle
protein, PscF, is 9 kDa.
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2.3.3.1 P. aeruginosa strain selection
The needles were isolated from the surface of P. aeruginosa, but selection
of an appropriate strain was necessary to facilitate needle purification. Since
needle purification involves sheering of the needle, it is necessary to limit
contaminants that can be obtained in the sheered in the process. One major
component is the flagella. To avoid contamination with flagella, the aflagellated
strains PA103 and the mutant CHAΔFliC were selected. PA103 is an aflagellated
clinical isolate strain (Liu and Hsieh, 1973; Montie et al., 1982). CHA is a cystic
fibrosis clinical isolate strain (Toussaint et al., 1993). The CHAΔFliC mutant does
not express the flagellin protein FliC (Pastor et al., 2005). After sheering protein
from the cell surface, a greater amount of 9 kDa protein was obtained from
CHAΔFliC than from PA103 (Fig 2.5), suggesting a greater amount of PscF, and
therefore needles, were obtained from this strain. Therefore the CHAΔFliC strain
was selected for further needle purifications. Additionally, needles have been
purified from this strain previously (Pastor et al., 2005).
There was a large amount of contaminating protein present after
purification of the needles (Fig 2.6). It would be ideal to utilize a mutant strain that
produces more T3S apparatuses on the surface, to increase the amount of
needles. It is possible to increase T3S apparatus production by stimulating T3S,
which can be induced in P. aeruginosa by cultivating in a low calcium
environment (Cornelis et al., 1987; Pettersson et al., 1996).
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Figure 2.6. A greater amount of 9 kDa protein was obtained from the
surface of CHAΔFliC than PA103. CHAΔFliC and PA103 were cultivated as
described in 2.5.4.1. Proteins were isolated from the surfaces of the bacteria by
vortexing for 5 minutes at 4°C. Twenty microliters of undiluted protein were run
on a 15% acrylamide Tricine SDS-PAGE and stained with Coomassie (see
Methods 2.5.4.4). The P. aeruginosa strain from which the sample was isolated
is indicated at the top. A strong 9 kDa band indicating the presence of PscF is
seen in proteins isolated from CHAΔFliC (arrow), but not from PA103. Molecular
weights are indicated.

17

2.3.3.2 Shearing needles and purification
Previous studies indicate that T3S needles can be sheared by moderate
agitation of the cells. These methods include resuspending the cells in buffer
(Pastor et al., 2005; Baylock et al., 2010), passage through a needle (Espina et
al., 2006), or vortexing (Journet et al., 2003). Other, more aggressive methods
have been used including sonication and homogenization (Jessen et al., 2014;
Hoiczyk and Blobel, 2001). Different needle shearing methods were examined
(see Methods 2.5.4.3). The results from all methods except sonication are the
same as those with gentle resuspension in buffer (Fig 2.7). Sonication increased
the amount of protein (Fig 2.7, lane 5), but a similar protein distribution was
observed by SDS-PAGE of proteins obtained by all shearing methods. A 9 kDa
protein was obtained from all of the shearing methods. This suggests that simply
washing the cells in buffer is sufficient to remove needles, and a more aggressive
treatment is unnecessary and may only serve to increase contaminating protein.
The large amount of contaminants in the needle purification could not be
removed. Type III Secretion was stimulated to induce greater needle production,
but this also increases protein secretion. A similar protein distribution was
observed by SDS-PAGE of proteins isolated from the growth media, as from the
needle purification (although the growth media was less concentrated) (Fig 2.7,
lane 6). Therefore it is likely that a large amount of the contaminating protein was
secreted protein. This indicates that the method of purification was not sufficient
to remove the secreted components. Washing the bacteria to remove the
secreted components is not ideal as even gentle washing is likely to remove
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Figure 2.7. Alternative needle shearing methods did not affect protein
obtained. CHAΔFliC was cultivated as stated in 2.5.4.1. Needles were sheared
from the surfaces of bacteria by resuspension (lane 1), homogenization (lane 2),
passing through an 18G needle (lane 3), vortexing (lane 4), or sonication (lane 5)
(see Methods 2.5.4.3). Growth media isolated from the same cultivated cells was
also analyzed (lane 6). Samples were run on a 15% acrylamide Tricine SDSPAGE and stained with Coomassie (see Methods 2.5.4.4). Molecular weights are
indicated.
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needles. The large amount of contaminants also hindered the ability to identify
needles by transmission electron microscopy.
The final step of the purification protocol involves centrifugation of the
protein, after which the pellets containing the needles were resuspended in
buffer. A similar protein distribution was observed by SDS-PAGE of the
supernatant as the purified needles (Fig 2.8, lanes 2 and 3), suggesting these
isolates contained the same proteins. Additionally, the needle tip component,
PcrV, was not enriched, and it was present in equal amounts in the supernatant
and pellet (Fig 2.9). Therefore it is likely that this step did not effectively remove
contaminating proteins or concentrate the needles. No pellets were observed
after centrifugation even when the starting culture volume was increased eight
fold, so it is likely that the resuspended pellet was merely residual supernatant
that was diluted. It is likely that the amount of needles present at the beginning of
the purification was very low, so no pellets were obtained. Protein purified using
Method B (see Methods 2.5.4.2) did not enter the SDS-PAGE gel, and it is
therefore unclear whether needles were successfully purified using this
alternative method.
2.4 Discussion and future research
While the unmodified recombinant PcrV purification was successful, it was
difficult to purify the T3S needles. While a band at 9 kDa was present when the
sample was separated on an SDS-PAGE, it was unclear if this protein was the
needle protein, PscF. Transmission electron microscopy could be performed with
the purified fractions, but the large amount of contaminating proteins would likely
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Figure 2.8. Needle precipitation by centrifugation. T3S needles were purified
from CHAΔFliC using Method A (see Methods 2.5.4.1). Needles were sheared
from the surfaces of bacteria by vortexing (see Methods 2.5.4.3). The needles
were precipitated by centrifugation (20,000xg, 30 min, 4°C). The pellet containing
the purified needles was resuspended and analyzed (lane 1). The supernatant
after precipitation was also analyzed (lane 2). The supernatant contained a large
amount of protein and was diluted 1:10 (lane 3). Samples were run on a 15%
acrylamide Tricine SDS-PAGE and stained with Coomassie (see Methods
2.5.4.4). Molecular weights are indicated.
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Figure 2.9. PcrV is present in needle fraction but not enriched with
purification. T3S needle purification fraction was prepared from CHAΔFliC using
Method A (see Methods 2.5.4.1). Needles were sheared from the surfaces of
bacteria by vortexing (see Methods 2.5.4.3). Aliquots from the purification steps
were analyzed before filtering (lane 1) and after filtering (lane 2). The supernatant
after precipitation of the needles was analyzed (lane 3) along with the purified
needle fraction (lane 4). Samples were run on a 10% acrylamide SDS-PAGE and
transferred to a PVDF membrane. PcrV was detected with polyclonal anti-PcrV
antibodies. Molecular weights are indicated at left. Interestingly, PcrV dimers
were present in the needle purification fractions.
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make it difficult to visualize any needles present. The purification method must be
modified to decrease contaminants and concentrate PscF.
The failure to purify T3S needles suggests that needles may not be
present at the start of the purification. This could be determined if a western blot
were performed with an anti-PscF antibody, which is not available. No significant
amount of protein was lost through the steps of the purification, so it is unlikely
that the needles were lost. It is also unlikely that the bacteria were not producing
needles. It is more likely that a low amount of needles were produced, because
the cells were not grown for a long enough time. It is also possible that the
needles were not sheared successfully from the bacteria, but unlikely. Washing
the cells is sufficient to remove needles from Yersinia (Journet et al., 2003), and
was the method used to shear needles from P. aeruginosa previously (Pastor et
al., 2005). In fact, free needles are found in the culture media of Shigella flexneri,
suggesting that T3S needles are quite fragile (Cordes et al., 2003; Olive et al.,
2007). Gentler shearing methods, like washing the cells, yielded similar results to
more aggressive methods like sonication and homogenization. This suggests
that very little disruption is needed to remove proteins attached to the surface of
P. aeruginosa. Furthermore, sonication and homogenization have potential to
lyse the cells, increasing contaminants significantly.
Monomeric PcrV alone, and in the presence of putative T3S needles did
not bind the PopB:PopD heterocomplex reconstituted in model membranes. If
this interaction does occur, it is likely that oligomeric PcrV is necessary, as the tip
complex is an oligomer of PcrV (Mueller et al., 2005). The T3S needles contain
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the tip complex and therefore could provide the oligomeric PcrV necessary to test
this hypothesis. In fact, PcrV dimers were detected in purified needle samples.
Purification of the T3S needles was difficult and therefore, unless the needles are
purified, an alternative source of oligomeric PcrV is needed to test this
hypothesis. One possibility is to measure the interaction directly with P.
aeruginosa by determining if the cells can interact with the heterocomplex
through the T3S needle.
These results suggest that the heterocomplex formed in model
membranes does not interact with the P. aeruginosa T3S system, but it is
possible that these T3S components cannot bind the heterocomplex
independently. The T3S system is a tightly regulated system, and the infection
mechanism likely requires very precise interaction of the needle with the
translocon, since no secreted protein is lost into the extracellular environment.
Therefore it is likely that P. aeruginosa modulates the interaction with the
translocon, and therefore must be present for the needle to engage with it.
2.5 Methods
2.5.1 Reconstituting the heterocomplex in model membranes
Binding reactions (75 μL) were prepared by equilibrating liposomes (65%
POPC, 20% cholesterol, 15% POPS, Avanti Polar Lipids) to a final concentration
of 5.94 mM in 50 mM sodium acetate, pH 4.3. The translocators were added to a
final concentration of 900 nM PopB and 90 nM PopD from a premixed stock in 6
M urea, 20 mM Tris pH 8.0, 20 mM glycine, 20 mM NaCl. After a 15 minute
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incubation at 23°C, the pH of the binding reactions were neutralized with 2 μL of
2 M Trizma, pH 9.0.
2.5.2 Isolating membrane-bound components with a flotation assay
Flotation assay was performed as in Romano et al., 2011. Purified PcrV
was added to membrane bound heterocomplexes to a final concentration of 900
nM (in 75 μL). The sample was incubated for 15 minutes at 23°C before mixing
with 225 μL of a 67% sucrose solution. A 40% sucrose solution was layered on
top (360 μL), followed by a 4% sucrose solution (240 μL). All sucrose solutions
were prepared in 30 mM sodium acetate, 30 mM 2-(N-morpholino)ethanesulfonic
acid (MES) pH 7.0. The sample was centrifuged for 50 minutes at 90,000xg, 4°C.
The sucrose gradient was separated into 300 μL aliquots, removing from the
bottom layer. A trichloroacetic acid (TCA) precipitation was performed with the
top layer containing the membrane-bound fraction using 15 μg of bovine serum
albumin as a carrier protein. A western blot was performed to detect for the
presence of PcrV in the membrane-bound fraction using a polyclonal anti-PcrV
antibody.
2.5.3 Unmodified recombinant PcrV purification
Twenty milliliters of an overnight culture of the E. coli expression strain
BL21(DE3)star (Invitrogen) expressing a pAH50-PcrV plasmid in Luria-Bertani
(LB) broth was diluted in 1 L LB containing 100 μg/mL ampicillin. The culture was
incubated at 37°C with shaking (150 rpm) until the optical density at 600 nm
(OD600) reached 0.60 (~3.5 hours), at which point Isopropyl α-Dthiogalactopyranoside (IPTG, Gold Biochemicals) was added to a final

25

concentration of 1 mM to induce PcrV expression. After an additional four hours
of incubation, the cultures were harvested by centrifugation (4,400xg, 15 min,
4°C). The cell pellets were resuspended in 50 mM Tris-HCl, pH 8.8, and protease
inhibitors were added (40 μg/mL PMSF and 170 μg/mL Benzamididine). The
cells were lysed by passing through a Microfluidics M-110L microfluidizer two
times at 18,000 psi. The cell lysate was centrifuged (20,000xg, 15 min, 4°C)
retaining the supernatant.
An ammonium sulfate precipitation with 30-70% gradient was performed
with the cleared cell lysate as follows. Ammonium sulfate was added with
constant stirring to a final concentration of 30% w/v at 4°C. After stirring for 30
min, the solution was centrifuged (10,000xg, 10 min, 4°C), and the supernatant
was retained. The precipitation was repeated with 70% ammonium sulfate, and
the pellet was retained after centrifugation. The pellet was resuspended and
dialyzed against 50 mM Tris-HCl, 100 mM NaCl, pH 8.0.
The sample was loaded onto a Q-Sepharose AEC column (GE
Healthcare) equilibrated with 50 mM Tris-HCl, pH 8.0. A 50 mL gradient of 50500 mM NaCl in 50 mM Tris-HCl, pH 8.0 was applied to elute PcrV. PcrV eluted
in 150-300 mM NaCl. Peak fractions (detected by absorbance at 280 nm) were
separated on an SDS-PAGE to confirm that PcrV was present, before pooling
and dialyzing overnight against 50 mM Hepes, 150 mM NaCl, pH 7.5. The
sample was concentrated with a Vivaspin 20 concentrator with a 10 kDa cutoff
(GE Healthcare), and applied to a Superdex-200 GL 10/30 column (GE
Healthcare). PcrV eluted in 11-14 mL. Peak fractions (detected by absorbance at
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280 nm) were separated on an SDS-PAGE to confirm that PcrV was present,
before pooling and dialyzing overnight against 20 mM MES, pH 6.5. The dialyzed
sample was loaded onto a Hi-Trap Q-HP column (GE Healthcare) equilibrated in
20 mM MES, pH 6.5. A 50 mL gradient of 0-500 mM NaCl in 20 mM MES, pH 6.5
was applied to elute PcrV. PcrV eluted in 475-500 mM NaCl. Peak fractions
(detected by absorbance at 280 nm) were separated on an SDS-PAGE to
confirm that PcrV was present, before pooling and adding glycerol (to 10% v/v).
The purified protein was aliquoted and flash frozen in liquid nitrogen before
storage at -80°C.
2.5.4 Needle purification
2.5.4.1

Method A

Method A was adapted from Gebus, 2008. An overnight culture of P.
aeruginosa (CHAΔFliC or PA103) in LB was diluted to an OD of 0.1 in 1 L LB. A
low calcium environment was created to induce T3S by chelating calcium with
EDTA (5 mM final concentration). The CHAΔFliC strain was graciously provided
by Ina Attrée (Université Grenoble Alpes). After chelating the calcium, the media
was supplemented with MgCl2 (20 mM final concentration). Cells were cultivated
at 37°C with shaking (150 rpm) until the cells reached an OD600 of 0.8 (~3 hours).
The cells were pelleted (8,000xg, 10 min, 4°C). Cells were resuspended at 4°C in
10 mL 50 mM Tris-HCl, pH 7.5 and needles were sheared. Cells were removed
by centrifuging (8,000xg, 10 min, 4°C) followed by passing the supernatant
through a 0.45 μm acetate membrane (Whatman). Needles were precipitated by
centrifugation (20,000xg, 30 min, 4°C). The pellet was resuspended in 1 mL 50
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mM Tris-HCl, pH 7.5. Needles were aliquoted and flash frozen in liquid nitrogen
before storing at -80°C.
2.5.4.2

Method B

Method B was adapted from Pastor et al., 2005. P. aeruginosa (CHAΔFliC
or PA103) cells were cultivated as in 2.5.4.1. The cells were pelleted (5,700xg,
10 min, 4°C). Cells were resuspended with 30 mL 20 mM Tris-HCl, pH 7.5 and
needles were sheared. Cells were removed by centrifuging (5,700xg, 10 min,
4°C) followed by passing the supernatant through a filter as in 2.5.4.1. Needles
were pelleted by centrifugation (18,000xg, 30 min, 4°C). The pellet was
resuspended in 15 mL Tris-HCl 20 mM, pH 7.5 with 0.1% (w/v) 3-((3cholamidopropyl) dimethylammonio)-1-propanesulfonate (CHAPS). Insoluble
protein was removed by centrifugation (50,000xg, 30 min, 4°C). The needles
were precipitated on ice for 1 hour with 10% (w/v) polyethylene glycol (PEG)
6000 and 100 mM NaCl. Needles were collected by centrifugation (50,000xg, 30
min, 4°C). The pellet was resuspended in 1 mL 20 mM Tris-HCl, pH 7.5. Needles
were aliquoted and flash frozen in liquid nitrogen before storing at -80°C.
2.5.4.3

Needle shearing methods

Several needle-shearing methods were attempted:


Washing: Cells were resuspended gently in buffer (50 mM Tris-HCl, pH
7.5) by incubating on ice with shaking (100 rpm) until the pellets were
completely resuspended (Pastor et al., 2005; Journet et al., 2003).



Vortexing: Cells were resuspended in buffer (50 mM Tris-HCl, pH 7.5)
and vortexed for 5 minutes at 4°C (in a cold room). Cells were vortexed for
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five 1 minute intervals with a 1 minute incubation on ice between (Gebus,
2008; Blaylock et al., 2010).


Sonication: Cells were resuspended in buffer (50 mM Tris-HCl, pH 7.5)
and the cell suspension was sonicated at maximum amplitude for one
second on ice. This was repeated five times.



Homogenization: Cells were resuspended in buffer (50 mM Tris-HCl, pH
7.5) and the cell suspension was transferred to a glass homogenizer and
the sample was homogenized for fifty cycles (Jessen et al., 2014; Cordes
et al., 2003).



Passing through a needle: After resuspending cells in buffer, cells were
passed through a 25G needle five times (Zhang et al., 2007; Espina et al.,
2006; Mueller et al., 2005).

2.5.4.4 Tricine SDS-PAGE
The Tricine SDS-PAGE protocol was adapted from Schägger and von
Jagow, 1987. The gel recipe is included in Table 2.1. A 15% acrylamide
separating gel was poured and allowed to polymerized for 30 minutes before
pouring a 4% stacking gel. Samples were prepared with sample buffer (180 mM
Trizma, 15% v/v glycerol, 7.5 mM EDTA, 0.02% w/v bromophenol blue, 3.65%
w/v SDS), heated to 95°C for 5 minutes, and loaded onto the gel. The gel was
run in a Mini-Protean gel running apparatus (Bio-Rad). The cathode buffer
contained 100 mM Tris, 100 mM Tricine, 0.1% SDS, pH 8.25. The anode buffer
contained 100 mM Tris, 22.5 mM HCl, pH 8.9. Gels were run at 60 V until the dye
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front entered the stacking gel after which the voltage was increased to 100 V until
the dye front reached the bottom of the gel.
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4% Stacking

15% Separating

Acrylamide (30%)

0.83

5

0.5 M Tris 8.8

—

1.875

0.5 M Tris 6.8

1.26

—

Add water to final volume

2.77

2.925

SDS (10%)

0.05

0.1

APS (10%)

0.05

0.1

TEMED

0.004

0.004

Polymerize by adding:

Table 2.1. Gel recipe for Tricine SDS-PAGE. Adapted from Schägger and von
Jagow, 1987. The components of the stacking and separating gel are indicated
along with the volume in mL. Recipe makes two 8.3 cm x 7.3 cm 15% acrylamide
gels.
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CHAPTER 3
INTERACTION OF P. AERUGINOSA WITH TRANSLOCATORS
RECONSTITUTED IN MODEL MEMBRANES
3.1 Introduction
Monomeric PcrV did not interact with the translocator heterocomplex
reconstituted in model membranes (see 2.3.2). It is likely that PcrV must be in an
oligomeric state to interact with the heterocomplex, however oligomeric PcrV was
difficult to isolate (C. Sanchez, unpublished data), and T3S needles (containing
the PcrV tip complex) were also difficult to isolate. As an alternative method to
study this interaction, live P. aeruginosa cells were utilized. By incubating P.
aeruginosa with the translocator heterocomplexes reconstituted in model
membranes, the functionality for interaction of the heterocomplex with other
components of the T3S system was studied.
3.1.1 Experimental design
To measure P. aeruginosa interaction with the membrane-reconstituted
heterocomplex, binding of the bacteria to liposomes was measured. The P.
aeruginosa strain PA103ΩPopD was selected for this assay, because it does not
produce the translocators PopB and PopD. This prevented any interactions
between the bacteria and liposomes through translocators produced by the
bacteria. To track liposomes, a fluorescent lipid was added.
3.1.1.1

Liposome composition

It has been shown that liposomes could interact with bacteria (DrulisKawa, and Dorotkiewicz-Jach, 2010). Therefore it was important to select a
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liposome composition that minimized interactions between the liposomes and P.
aeruginosa for binding through the translocator complexes to be accurately
measured. Bucki et al. showed that inclusion of a charged fluorescent label
increases interaction with P. aeruginosa (2004). Additionally, previous studies
indicate P. aeruginosa binds to liposomes containing Rhodamine-1,2dihexadecanoyl-sn-glycero-3-phosphoethanolamine (DHPE) (F. Romano,
unpublished results). This phospholipid contains a charged Rhodamine moiety
on the head group such that it is accessible to the bacteria. NBD-cholesterol was
selected for these experiments because the NBD label is buried in the lipid
bilayer, and no charged residues are exposed on the membrane surface. This
fluorophore selection will minimize any dye-bacteria interaction. The lipid
composition POPC:cholesterol:POPS:NBD-cholesterol at molar ratio
65:19.8:15:0.2 was selected as it maximizes assembly of the translocator
complexes in model membranes (Romano et al., 2011).
3.1.1.2

Heterocomplexes cannot be formed in the absence of homooligomers

The translocators were reconstituted in membranes before incubating with
bacteria. The PopB:PopD heterocomplex is formed by incubating one
translocator (PopB) in a ten times excess of the other (PopD); this ensures all of
the PopD present is in a heterocomplex, so the amount of heterocomplex present
in a sample is known (Romano et al., submitted). Since the heterocomplex is a
complex of eight PopB and eight PopD, only 18% of the total protein present was
in a heterocomplex, and the remaining 82% consisted of PopB homo-oligomers
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(Fig 3.1, A). Therefore binding to the PopB homo-oligomers contributed to the
signal obtained when measuring binding to the heterocomplex, so binding to
PopB homo-oligomers (in the absence of PopD) was also measured. Binding to
PopD homo-oligomers was measured as well for a comparison.
3.1.1.3

Assay to measure P. aeruginosa-liposome interactions

The binding of P. aeruginosa to liposomes was measured as follows. The
translocators were reconstituted in liposomes (Fig 3.2, A), and the liposomes
were then incubated with bacteria (Fig 3.2, B). Cells were pelleted along with any
bound liposomes (Fig 3.2, C). The pellets were resuspended and liposome
binding was measured by measuring the fluorescence emission intensity of the
liposomes (Fig 3.2, D). Higher fluorescence emission intensity indicated greater
liposome binding. These measurements were also performed with liposomes
without membrane-bound translocators to measure nonspecific binding of the
bacteria to liposomes.
3.2 Results and discussion
3.2.1 Binding of P. aeruginosa to liposomes is enhanced when the
heterocomplex is present
The interaction between PA103ΩPopD and liposomes containing
reconstituted translocator complexes was measured using the assay described in
3.1.1.3. Binding to the heterocomplex as well as both PopB and PopD homooligomers was measured. Binding was greatest when the heterocomplex was
present (Fig 3.3, red). The relative fluorescence emission for the heterocomplex
sample was 36% greater than that of the PopB homo-oligomer sample. Since
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Figure 3.1. Heterocomplexes cannot be formed in the absence of homooligomers. PopB and PopD form homo-oligomers as well as heterocomplexes in
model membranes (Romano et al., submitted). Therefore, to reconstitute the
PopB:PopD heterocomplex in liposomes, PopB was added in a ten times excess
of PopD. (A) When forming the heterocomplex, all of the PopD (blue) was
incorporated into heterocomplexes while PopB (green) also formed homooligomers on the liposomes (yellow). Therefore there were more PopB homooligomers than heterocomplexes present, and the number of PopB homooligomers present was about the same as the number present in (B) the sample
containing only PopB homo-oligomers.
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Figure 3.2. Measuring the interaction between P. aeruginosa and the
heterocomplex. (A) Translocator complexes of PopB (green) and PopD (blue)
were reconstituted in liposomes (yellow) labeled with NBD-cholesterol (red dots).
(B) P. aeruginosa (purple) was incubated with liposomes to allow for interaction
with the T3S needle (black). (C) Cells were pelleted along with bound liposomes.
(D) The pellet was resuspended and fluorescence emission of NBD-cholesterol
was measured to measure the amount of liposome binding. Binding to liposomes
without translocators was measured in the same way. Model not drawn to scale.
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Figure 3.3. P. aeruginosa binds to Liposomes with membrane-bound
translocators. P. aeruginosa interactions with fluorescently-labeled liposomes
containing translocator heterocomplexes (red) or homo-oligomers of PopB (blue)
or PopD (red) were measured with fluorescence spectroscopy (Methods section
3.4.1). Translocator complexes (homo-oligomers and heterocomplexes) were
reconstituted on liposomes (amounts in each sample indicated at bottom).
Protein:lipid ratio was 1:6000, with lipid composition
POPC:cholesterol:POPS:NBD-cholesterol at molar ratio 65:19.8:15:0.2.
PA103ΩPopD was grown to OD600 of 1.2 under conditions that induced T3S (see
Methods 3.5.4.1). Cells were washed and diluted in PBS to OD600 of 0.25 before
incubating with the liposomes. Fluorescence emission intensity was normalized
to the maximum fluorescence value. Binding to liposomes lacking translocators
was subtracted. Error bars indicate the standard deviation between at least three
independent measurements.
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only 18% of the heterocomplex sample consists of heterocomplexes, this large
increase in fluorescence was due to a small amount of protein.
Binding to PopB and PopD homo-oligomers appears to be dependent on
the amount of protein present. The amount of PopB was ten times greater than
PopD in their respective homo-oligomer samples, and the relative fluorescence
emission of the sample containing PopD homo-oligomers was 8% of that of the
PopB homo-oligomer sample (Fig 3.3, blue and green). This dependence on
protein amount was not true for the sample containing heterocomplexes, which
only contained 10% more protein than the PopB homo-oligomer sample. These
results indicate that binding to of P. aeruginosa to liposomes is enhanced in the
presence of the heterocomplex compared to the homo-oligomers.
3.2.2 BSA blocked P. aeruginosa interactions with PopB and PopD
independently of their oligomeric arrangement
It was possible that the interactions seen between bacteria and liposomes
were due to nonspecific protein-protein interactions. Bovine serum albumin
(BSA) can be added to cells to block nonspecific protein-protein interactions
(Deng et al., 2007). BSA was added to P. aeruginosa to a final concentration of
1% before incubating with liposomes. BSA did not affect binding to liposomes
without translocators (data not shown). When BSA was present, the relative
fluorescence emission of the sample containing heterocomplexes decreased to
0.20 ± 0.03 RFUs (Fig 3.4, purple). The relative fluorescence emission of the
PopB homo-oligomer sample decreased similarly, to 0.25 ± 0.034RFUs (Fig 3.4,
orange). In both cases, binding was not blocked entirely.
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Figure 3.4. Adding BSA to P. aeruginosa blocked binding to translocators.
P. aeruginosa interactions with liposomes with membrane-bound translocator
complexes after blocking cells with 1% BSA (+BSA) or not, were measured using
fluorescently labeled liposomes (see Methods 3.4.1). Heterocomplexes (purple)
and PopB homo-oligomers (orange) were reconstituted on liposomes
(heterocomplex: 4.3 pmol PopB and 0.43 pmol PopD), (homo-oligomer: 4.3 pmol
PopB). Protein:lipid ratio was 1:6000, with lipid composition
POPC:cholesterol:POPS:NBD-cholesterol at molar ratio 65:19.8:15:0.2.
PA103ΩPopD was grown to OD600 of 1.2 under conditions that induced T3S,
cells were washed and diluted in PBS with or without 1% BSA to OD600 of 0.25
before incubating with proteoliposomes. Fluorescence emission intensity was
normalized to the maximum fluorescence value. Nonspecific binding to
liposomes lacking translocators was subtracted. Error bars indicate the range
between at two independent measurements.
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These results do not show any specificity for P. aeruginosa binding to the
heterocomplex compared to the PopB homo-oligomer, as the binding
enhancement seen in the presence of the heterocomplex was lost upon addition
of BSA. One percent BSA blocks a large amount of protein-protein interactions
between P. aeruginosa and the translocators in either oligomeric state,
suggesting that at least some of interactions between are nonspecific.
It is possible that BSA blocked specific interactions with complexes
reconstituted in liposomes. BSA is commonly used to block nonspecific
interactions when host cells are present (Raybourne and Bunning, 1994). In the
presence of a host cell, bacterial adhesins can recognize the host and aid in the
bacterial-host interaction. In this study, model membranes were selected in place
of eukaryotic cells. Therefore factors that normally would aid in the cellular
interactions are not present, and therefore BSA could have a more significant
effect on binding, such as interfering with specific protein-protein interactions.
3.2.3 P. aeruginosa bound translocator complexes without the T3S
apparatus
It is possible to determine if binding to the membrane-reconstituted
heterocomplex is dependent on the T3S system, by measuring the interactions
with a mutant that does not produce the T3S apparatus. The PAKΔPscC mutant
was selected for these experiments because it lacks the secretin component of
the T3S apparatus and therefore does not produce the apparatus or secrete any
effectors (Lee et al., 2005). Wild-type PAK was selected as a control.
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Binding of P. aeruginosa to liposomes with and without the heterocomplex
was compared. In the previous experiments (3.2.1 and 3.2.2) nonspecific binding
to liposomes was subtracted from the measurements. Here the binding of the
T3S apparatus was in question, not the translocator complexes present, and
therefore liposome binding was included in the comparison. The relative
fluorescence of the sample containing PAK plus liposomes with or without
translocators was similar (Fig 3.5, blue), suggesting PAK bound liposomes with
and without translocators equally. The relative fluorescence of the sample
containing PAKΔPscC plus liposomes was lower when the heterocomplexes
were absent (Fig 3.5, red). This suggests that binding of the PAKΔPscC mutant
increased when heterocomplexes were present (Fig 3.5, red). These results
suggest that P. aeruginosa does not bind to the heterocomplex through the T3S
apparatus.
The heterocomplex sample contained PopB homo-oligomers, since PopB
was added in excess to force all of the PopD into heterocomplexes (Fig 3.1, A).
In some bacterial species, T3S translocators, when in a different oligomeric state,
perform alternative functions in addition to translocation. For example, in the
Shigella T3S system, IpaC functions to translocate effectors when in complex
with IpaB, however in its homo-oligomeric state it performs a different role
(Osiecki et al., 2001; Mounier et al., 2009). It is therefore possible that PopB
homo-oligomers and PopB:PopD heterocomplexes both play a role
physiologically. If the PopB homo-oligomers interact with the bacteria through a
structure other than the T3S apparatus, then binding would still occur in the
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Figure 3.5. P. aeruginosa binds to the heterocomplex in the absence of the
T3S apparatus. P. aeruginosa interactions with fluorescently-labeled liposomes
with and without translocators bound were measured when the T3S apparatus
was present (blue) or absent (red) (see Methods 3.4.1). Translocator
heterocomplexes were reconstituted on liposomes (4.3 pmol PopB and 0.43
pmol PopD). Composition of each sample is indicated at bottom. Protein:lipid
ratio was 1:6000, with lipid composition POPC:cholesterol:POPS:NBDcholesterol at molar ratio 65:19.8:15:0.2. PAK or PAKΔPscC (no T3S apparatus)
was grown to OD600 of 1.2 under conditions that induced T3S; cells were washed
and diluted in PBS to OD600 of 0.25 before incubating with liposomes.
Fluorescence emission intensity was normalized to the maximum fluorescence
value. Error bars indicate the range between two independent measurements.
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ΔPscC mutant. Binding to PopB homo-oligomers alone was not measured,
however, so it is not clear how much this contributed to the signal. Therefore it is
not clear if one translocator oligomer was active to interacting with the bacteria
when the T3S apparatus was absent.
Wild-type PAK produced the translocators PopB and PopD, and secreted
them into the media (data not shown), however is unclear whether these
translocators are inserted into liposomes. The hydrophobic translocators
aggregate in solution (Tardy et al., 1999; Hume et al., 2003), so even if PAK did
not insert these translocators, secreted translocator aggregates likely stuck to the
liposomes. The liposomes may have become saturated with translocators.
Binding to these translocators (even if nonspecific) may have made the
reconstituted translocator complexes inaccessible, explaining why the
fluorescence signal did not increase when the heterocomplex was present (Fig
3.5, blue). These results exemplify the importance of using a mutant strain that
does not produce the translocators to measure interactions with the translocator
complexes in liposomes.
3.3 Conclusion
The use of fluorescently labeled liposomes to assay P. aeruginosa binding
allowed for bacteria-liposome interactions to be measured efficiently. Measuring
interactions between the bacteria and the membrane-reconstituted translocators
was possible, however it was difficult to determine if these interactions occurred
through the T3S apparatus. There was a broad distribution of the binding data
obtained. The assay used is an innovative method developed to allow for a more
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high-throughput measurement of liposome-bacteria interactions than
fluorescence microscopy. While Luisi et al. used a similar method to measure
liposome binding, the application of this method to identify bacterial-protein
complex interactions is novel and likely needs to be modified to increase
precision and reproducibility of measurements (Luisi et al., 1998).
Despite possible limitations in the assay, it is clear that P. aeruginosa
more readily binds the reconstituted heterocomplex than homo-oligomers of
either translocator. The interactions may be weak, but entropically favored when
the translocon is inserted in close proximity of the needle in vivo when the
bacteria are attached to the host cell. Further research is necessary to determine
if the heterocomplex reconstituted in model membranes is functional for this type
of interaction.
3.4 Methods
3.4.1 Measuring P. aeruginosa binding to translocator complexes in
liposomes
Homo-oligomers and heterocomplexes were reconstituted in liposomes
(37.5 μM) (65% POPC, 19.8% cholesterol, 15% POPS, 0.2% NBD-Cholesterol,
Avanti Polar Lipids) as described in 2.5.1, with the final concentration of PopB
and PopD being 56.8 nM and 5.68 nM respectively. The pH was neutralized with
2 μL of 2 M Trizma pH 9.00. Homo-oligomers were formed with either 56.8 nM
PopB or 5.68 nM PopD in 37.5 μM liposomes. PA103ΩPopD was cultivated as in
2.5.4.1 to induce T3S. Cells were grown until they reached an OD600 of 1.2. Cells
were washed in PBS, pH 7.2 and collected by centrifugation (600xg, 10 min,
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4°C). The cell pellet was resuspended in 10 mM phosphate, 137 mM NaCl, 2.7
mM KCl, pH 7.2 (PBS) and diluted to OD600 of 0.25. Four hundred and fifty
microliters of cells were transferred to a glass culture tube. Liposome-bacteria
interactions were measured using a protocol adapted from Luisi et al., 1998. To
the glass culture tube, 75 μL of proteoliposomes were added. Cells and
liposomes were incubated for 15 min with shaking (150 rpm), 23°C. Cells and
bound liposomes were pelleted (1,200xg, 10 min, 23°C). Pellets were
resuspended in 300 μL PBS, pH 7.2 and the fluorescence reading was taken by
exciting the sample at 485 nm (bandpass 5) and measuring emitted light at 550
nm (bandpass 5).
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CHAPTER 4
CHARACTERIZATION OF THE P. AERUGINOSA T3SS TRANSLOCON
ISOLATED FROM INFECTED RBCS
4.1 Introduction
The heterocomplex reconstituted in model membranes is a hexadecamer
of eight PopB and eight PopD (Romano et al., submitted). Since the molecular
weights of PopB and PopD are 40.3 kDa and 31.3 kDa respectively, the P.
aeruginosa heterocomplex is predicted to have a molecular weight of 601 kDa
(Romano et al., submitted). The molecular weight of the native P. aeruginosa
translocon has not been determined. The Y. enterocolitica T3S translocon
formed by contact with red blood cells (RBCs) has been isolated, and the
molecular weight of the complex was estimated to be between 500 and 700 kDa
using Blue Native (BN)-PAGE (Montagner et al., 2011). A BN-PAGE can be used
to roughly estimate the molecular weight of the P. aeruginosa translocon, which
will give insight into how it relates to the heterocomplex formed in model
membranes.
The heterocomplex reconstituted in model membranes has a 1:1
stoichiometry of PopB to PopD (Romano et al., submitted). This diverges from
the 5:1 translocator stoichiometry of the Shigella translocon (Dickenson et al.,
2013). The stoichiometry of the native P. aeruginosa translocon is not known.
The translocon, isolated by BN-PAGE, can be further analyzed in a second
dimension by a denaturing SDS-PAGE (Fiala et al., 2011). This will separate the
translocators present in the translocon, allowing for their relative amounts to be
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compared. If the translocon forms a 1:1 complex, an equal amount of PopB and
PopD will be detected. This will provide greater insight into the structure of the P.
aeruginosa translocon and will determine how the translocon formed in cell
membranes relates to the heterocomplex formed in model membranes.
4.2 Experimental Design
4.2.1 Inducing P. aeruginosa contact with RBCs
The translocon was to be isolated from mammalian cells. To perform the
analysis by BN-PAGE, a large amount of translocon complexes need to be
isolated (about 60 μg total protein per lane) (Montagner et al., 2011). This would
require a large amount of cultured cells. A good alternative is to use mammalian
RBCs. RBCs can be obtained in high amounts and lysis can easily be assessed.
T3S translocons have been isolated from RBC membranes after contact with Y.
enterocolitica (Montagner et al., 2011).
P. aeruginosa was incubated with RBCs at a multiplicity of infection (MOI)
of 3 (Fig 4.1, 1). Bacteria-RBC contact was inducted by centrifugation (Fig 4.1, 2,
B). The pelleted cells were incubated at 37°C to allow for the translocon
formation to proceed (Fig 4.1, 2, C). The cells were then resuspended (Fig 4.1, 2,
A). This process was repeated four times to increase cell contact, which
increased the number of translocons formed (Broz et al., 2007).
4.2.2 Isolating RBC membranes
After contact with P. aeruginosa, RBCs lyse (Goure, 2005) (Fig 4.1, 3).
The lysed RBCs were separated from bacteria by centrifugation (Fig 4.1, 4). RBC
membranes containing the translocon complexes were isolated from unbound
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Figure 4.1. Schematic of method used to induce P. aeruginosa contact with
RBCs. (1) P. aeruginosa (purple) was mixed with RBCs (red) at an MOI of 3 in a
3 to one ratio of 30 mM Tris-HCl, 150 mM NaCl, pH 7.4. (2) Translocons were
formed on RBCs by bacteria-RBC contact, which was facilitated by (B) pelleting
the cells (1,000xg, 10 min, 37°C). (C) Pellets were incubated for 10 minutes at
37°C and (A) resuspended by shaking (100 rpm, 2 min, 37°C). This procedure
was repeated three more times to maximize the number of translocons inserted.
(3) T3S protein injection induced RBC lysis. (4) Bacteria were removed by
centrifugation (1,500xg, 10 min, 4°C). (5) Lysed RBCs were mixed with sucrose
and a sucrose gradient was established. (6) RBC membranes were floated by
centrifugation. (7) RBC membranes were harvested by centrifugation.
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proteins and other cellular components by floating on a sucrose gradient (Fig 4.1,
5 and 6). The RBC membranes were pelleted and stored at -20°C (Fig 4.1, 7).
The proteins present on the RBC membranes were separated on an SDSPAGE and transferred to a polyvinylidene fluoride (PVDF) membrane. PopB and
PopD were detected with polyclonal antibodies. The presence of the
translocators would suggest that the translocon was present on the RBC
membrane.
4.2.3 Isolating the translocon from RBC membranes
The translocon was isolated from RBC membranes. The RBC membranes
needed to be solubilized with mild detergents to maintain the quaternary
structure of the translocon. Selecting detergents to dissolve the membrane
without disrupting the protein-protein interactions within the translocon complex
was not trivial. The ideal detergent for isolating membrane protein complexes
varies depending on the complex size and stability, as well as the charges and
hydrophobicity of the proteins in the complex (Linke, 2009). Since a BN-PAGE
was to be performed, a nonionic detergent needed to be selected (see 4.2.4).
Three nonionic detergents were selected for these experiments: Triton X-100,
digitonin, and n-Dodecyl β-D-maltoside (DDM).
The detergent concentration also has a significant impact on the
solubilization of a membrane protein complex. When detergents are added to
membranes, they are first incorporated into the membrane bilayer. As more
detergent is added, the membrane becomes saturated. The critical micellization
concentration (CMC) of a detergent is the concentration at which micelles begin
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to form (Linke, 2009). Once the membrane is saturated, if enough additional
detergent is added for the concentration of free detergent to rise above the CMC,
the membrane begins to solubilize (Lichtenberg, 2013). Therefore to fully
solubilize the membrane, the detergent concentration must not only be high
enough to saturate the membrane, but also high enough that the free detergent
concentration is above the CMC. The CMC is a property of a detergent that does
not change if the temperature remains constant (Linke, 2009). The amount of
detergent needed to saturate the membrane depends not only on the amount of
membrane present, but also on the membrane composition (Linke, 2009).
Therefore several different detergent concentrations were tested in their ability to
solubilize the RBC membranes to isolate the translocon.
4.2.4 Estimating the molecular weight of the translocon using BN-PAGE
After solubilization, a BN-PAGE could be performed to estimate the
molecular weight of the translocon. The BN-PAGE is a method that separates
membrane proteins using PAGE in non-denaturing (native) conditions. This
method is similar to SDS-PAGE in that a reagent is added to negatively charge
the proteins, a factor that distinguishes BN-PAGE from Native-PAGE. Coomassie
brilliant blue G250 binds to the hydrophobic regions of solubilized membrane
proteins, giving them a negative charge without denaturing the proteins
(Schägger et al., 1994). This causes all proteins to migrate in the same direction
in an electric field. For this reason, nonionic detergents must be used to
solubilize membrane protein complexes. Unlike SDS-PAGE, BN-PAGE cannot
be used to accurately calculate the molecular weight of a protein complex, but it
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can be useful to estimate oligomerization states.
The solubilized translocon isolated from RBC membranes was separated
by BN-PAGE. A gradient acrylamide gel was used to allow for the separation of
complexes with a broad range of molecular weights. A western blot was
performed to detect for the presence of the translocator proteins.
4.3

Results and Discussion

4.3.1 Translocators were found on RBC membranes after contact with P.
aeruginosa
The proteins present on the RBC membranes were separated on a 10%
acrylamide SDS-PAGE and transferred to a PVDF membrane. PopB and PopD
were detected with polyclonal antibodies. Lysed P. aeruginosa as well as RBC
membranes that did not come in contact with P. aeruginosa were included in the
gel as a control (Fig 4.2, A and B, lanes 2 and 3). RBCs membranes that did not
come in contact with P. aeruginosa were prepared by lysing RBCs with a
hypotonic solution. These RBC membranes were isolated from other cellular
components using a flotation assay (Fig 4.1, 5 and 6).
PopD was detected in the RBC membranes following contact with P.
aeruginosa. A band at the predicted molecular weight of PopD (31.3 kDa) was
detected (Fig 4.2, A, lane 1, arrow), however the anti-PopD antibodies detected
several other proteins in this sample. The ~37 kDa and ~80 kDa bands were also
present in the lysed bacteria (Fig 4.2, A, lane 2), suggesting this was nonspecific
binding of the antibody to a bacterial protein that was also found on RBC
membranes after contact with P. aeruginosa. The other bands were not detected
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Figure 4.2. Translocators were found on RBC membranes after contact with
P. aeruginosa. Translocators (A) PopD and (B) PopB were detected after
separation on a 10% acrylamide SDS-PAGE and transferring to a PVDF
membrane. (1) RBC membranes isolated by flotation assay after contact with P.
aeruginosa. (2) P. aeruginosa cell lysate after sonication. (3) RBC membranes
that did not come in contact with P. aeruginosa. Arrow indicates the predicted
migration of PopD in A, and PopB in B. Translocators were detected with
polyclonal anti-PopB and anti-PopD antibodies.
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in the RBC membranes that did not come in contact with P. aeruginosa (Fig 4.2,
A, lane 3), so they are not mammalian proteins. These other bands could be
secreted bacterial proteins that were not obtained when the bacteria were lysed.
A single band was detected at 40 kDa by the anti-PopB antibodies in the
RBC membranes following contact with P. aeruginosa (Fig 4.2, B, lane 1, arrow).
The anti-PopB antibodies detected several other proteins in the lysed bacteria
that were not present in the RBC membranes after contact with P. aeruginosa
(Fig 4.2, B, lane 2). This was likely due to nonspecific binding of the antibodies to
bacterial proteins. No proteins were detected in the sample containing RBC
membranes that did not come in contact with P. aeruginosa (Fig 4.2, B, lane 3).
The antibodies used for detection were polyclonal and were developed
using recombinant protein. These antibodies could be binding nonspecifically to
other proteins. This is likely why, in some samples, other bands were detected in
addition to the bands detected at the predicted molecular weights of PopB and
PopD. Using monoclonal antibodies developed against the native translocators
would minimize this nonspecific binding.
PopD and PopB were detected on RBC membranes only after contact
with the bacteria. These results suggest that P. aeruginosa inserted the
translocon into the RBC membranes.
4.3.2 Detection of translocon obtained from RBC membranes on BN-PAGE
The translocon on RBC membranes was solubilized in detergent (DDM)
and separated on a BN-PAGE. A sample solubilized in 1% SDS was included as
a control, since 1% SDS is predicted to completely dissociate the translocon
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complex into monomers (Montagner et al., 2011). Several bands were stained
with Coomassie (Fig 4.3), since RBC membranes contain many membrane
proteins that were likely isolated along with the translocons. The 3-20% gradient
gels could only separate protein complexes with molecular weights lower than
~500 kDa. The predicted molecular weight of the heterocomplex is 601 kDa. This
could explain why a lot of protein remained in the wells.
A western blot was performed to detect the translocator proteins PopB
and PopD (Fig 4.4). PopD was detected in RBC membranes solubilized in 3.5%
DDM and 1% SDS (Fig 4.4, A, lanes 1 and 7). A very faint band of PopB was
detected in the lane containing RBC membranes solubilized 1% SDS (Fig 4.4, B,
lane 7), however no PopB was detected in the lane containing RBC membranes
solubilized in 3.5% DDM (Fig 4.4, B, lane 1). It is possible that these bands do
not contain the translocator proteins, since nonspecific binding of both anti-PopB
and anti-PopD antibodies was seen in the previous western blots performed with
these antibodies (Fig 4.2),
The 3-20% gradient could only separate proteins up to 500 kDa; therefore
the bands detected were likely dissociated translocon complexes. Furthermore,
PopB and PopD bands did not migrate similarly, indicating that the translocon
complex quaternary structure was not maintained. These results suggest that
3.5% is too high of a concentration of DDM to maintain the quaternary structure
of the translocon. It also is possible that the molecular weight of the translocon is
less than predicted, and could therefore be separated by the 3-20% gradient gel
used. Unfortunately, the molecular weight marker did not stain with Ponceau
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Figure 4.3. Separation of translocon isolated from infected RBCs on BNPAGE with a 3-20% acrylamide gradient. After solubilizing in the indicated
detergent (right), samples containing isolated translocons were run on a 4-20%
gradient acrylamide (see Methods 4.4.3). Protein was detected by staining with
Coomassie. All lanes contain 30 μg of protein. Approximate molecular weights
are indicated.
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Figure 4.4. Detecting PopB and PopD in the translocon isolated from RBCs
after separating on a BN-PAGE. After solubilizing in the indicated detergent
(right), samples containing isolated translocons were run on a 4-20% gradient
acrylamide gel (see Methods 4.4.3). A western blot was performed to detect (A)
PopD and (B) PopB. All lanes (excluding the control, lane 3) contain 30 μg of
protein. Lane 3 contains a control sample containing 10 times the minimal
amount of protein detected by the antibodies (A) 100 ng PopD, or (B) 10 ng
PopB. Translocators were detected with polyclonal anti-PopB and anti-PopD
antibodies.
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after transferring to the PVDF membrane, so it was not possible to determine the
molecular weights of these bands.
Purified PopB and PopD were both detected in their respective control
lanes, however the translocators migrated very differently (Fig 4.4, A and B, lane
3). The BN-PAGE separates proteins by size, and no denaturing agent was
added (Wittig et al., 2006). PopD likely aggregated and this aggregate migrated
differently from monomeric PopD. In the future, purified translocator complexes
should be reconstituted in membranes and solubilized with detergents before
running on a BN-PAGE.
The BN-PAGE was repeated with a 3-12% acrylamide gradient gel to
allow for higher molecular weight complexes to be separated. Alternative
detergents and detergent concentrations were selected to solubilize the
membrane proteins to determine optimal conditions for solubilizing the
translocon. The BN-PAGE was stained with silver rather than Coomassie. Silver
staining is up to 100 times more sensitive than Coomassie (Chevallet et al.,
2006), and the marker was more easily visualized using this staining method. A
western blot was performed to detect PopD.
Unfortunately, there was a problem with the gel, which caused the inner
lanes to run much faster than the outer lanes. Many proteins were detected by
silver staining, indicating that proteins were entering the gel (Fig 4.5, A). The
molecular weight marker ran differently in the 3-12% gradient gel, separating
complexes as large as ~750 kDa. PopD was detected in all lanes at the top of the
wells, indicating the translocon was not fully solubilized (Fig 4.5, B). PopD
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Figure 4.5. Separation of translocon isolated from infected RBCs on BNPAGE with a 4-12% acrylamide gradient. After solubilizing in the indicated
detergent (right), samples containing isolated translocon were run on a 4-12%
gradient acrylamide gel (see Methods 4.4.3) Lanes 1-4 contain 30 μg of protein.
Lanes 6-9 contain 60 μg of protein. Protein was detected by (A) staining with
silver, or (B) transferring to a PVDF membrane and detecting for PopD.
Approximate molecular weights are indicated at left. PopD was detected with a
polyclonal anti-PopD antibody.
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solubilized with DDM and SDS entered the gel (Fig 4.5, B, lanes 2 and 6),
however these samples were run in duplicate on the gel and their duplicate
samples did not enter the gel. This was likely due to the gel not running properly.
Few conclusions can be drawn from this gel because it did not run properly,
however the results indicate that the 3-12% acrylamide gradient is appropriate for
isolating a 601 kDa complex, the predicted molecular weight of the membranereconstituted heterocomplex.
4.4 Methods
4.4.1 Inducing P. aeruginosa-RBC contact
An overnight culture of PAK was performed in 100 mL LB. Four 500 mL
LB cultures were inoculated with 25 mL of the overnight culture. The cells were
cultivated until they reached an OD600 of 1.10. Cultures were pooled before
splitting into four tubes and centrifuging to pellet cells (3,220xg, 10 min, 37°C).
Cell pellets were washed in 50 mL LB. Cell pellets were resuspended in a
minimum volume of LB (~1 mL). The number of bacteria present in each pellet
was estimated using the formula OD600 1.0 = 6x108 cells/mL (C. Rossi,
unpublished data).
RBCs were isolated from sheep blood with sodium heparin as an
anticoagulant (Innovative Research) by washing. Two hundred milliliters of sheep
blood was split into 20 mL aliquots in 50 mL centrifuge tubes. To each aliquot, 30
mM Tris-HCl, 150 mM NaCl, pH 7.4 was added to bring the volume to 45 mL.
The solution was resuspended gently by pipetting and then centrifuged to pellet
RBCs (500xg, 15 min, 4°C). This process was repeated three times or until the
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supernatant appeared clear. Washed RBCs were pooled and counted using a
cell counter. Protease inhibitors (Roche) were added to the RBCs.
An appropriate amount of RBCs were added to the bacteria to attain an
MOI of two. Bacteria were diluted in LB to maintain a 3:1 ratio by volume of
RBCs to bacteria. Cell contact was induced using a protocol modified from
Montagner et al., 2011. Cells were centrifuged (1,000xg, 10 min, 37°C) to induce
cell contact. The pellet was incubated at 37°C for 10 minutes before
resuspending by shaking (100 rpm) for 2 min at 37°C. This was repeated four
times.
The reaction was transferred to a 50 mL tube and centrifuged (1,500xg, 10
min, 4°C) to pellet bacteria. A flotation assay was performed with the supernatant
containing the lysed RBCs to isolate the RBC membranes. Flotation assays were
set up in 50 mL tubes to which 7.5 mL lysed RBCs were added along with 7.5 g
sucrose. The solution was vortexed gently to dissolve the sucrose, generating a
60% sucrose solution. The solution was overlaid with 12 mL 50% sucrose in 50
mM Tris-HCl, pH 7.4, followed by 10 mL of 25% sucrose solution in the same
buffer. The samples were centrifuged at 15,000xg, 16 hours, 4°C. The RBC
membranes were collected between the 25% and 50% sucrose layers.
The RBC membranes were pelleted (45,000xg, 60 min, 4°C). The pellets
were washed two times in 35 mL BN-PAGE sample buffer (50 mM Bis-Tris, 50
mM 6-aminohexanoic acid, 1 mM EDTA, pH 7.2). The pellet was resuspended in
a minimal volume of BN-PAGE sample buffer and the protein concentration was
determined using a bicinchoninic acid (BCA) assay (Pierce). The membranes
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were split into aliquots containing 400 μg of protein, and 10% glycerol was added
before pelleting (100,000xg, 30 min, 4°C). Pellets were stored at -20°C for
several weeks.
4.4.2 Isolating the translocon from RBCs after contact with P. aeruginosa
Infected RBC membrane pellets were thawed on ice. Detergent in BNPAGE sample buffer was added to the pellet. The pellet was resuspended gently
by pipetting up and down. Pellets were solubilized on ice on a shaker (50 rpm),
for one hour. When SDS or digitonin was used, pellets were solubilized at 4°C to
prevent precipitation of the detergent. Insoluble material was pelleted (20,000xg,
1 hour, 4°C). The supernatant contained the solubilized translocon as well as
other solubilized membrane proteins from the RBCs.
4.4.3 Separation of the translocon isolated from RBCs by BN-PAGE
Solubilized translocons were prepared for BN-PAGE by adding
Coomassie brilliant blue G250 in MilliQ water to a final concentration of 25% of
that of the detergent (Schägger et al., 1994). Ten percent glycerol was added to
the samples. A Bis-Tris 4-12% gradient gel (Genscript) was set up in a Bio-Rad
Mini Proteon electrophoresis apparatus. Initially a Bis-Tris 3-20% gradient gel
(Genscript) was used with poor separation of the complexes. Samples were
loaded onto the gel along with 5 μL of the NativeMark molecular weight marker
(Invitrogen). The cathode buffer contained 50 mM Bis-Tris, 50 mM Tricine, 0.02%
Coomassie brilliant blue G250, pH 6.8, while the anode buffer contained 50 mM
Bis-Tris, pH 6.8. The gel was run at 100 V at 4°C until the dye front reached one
third of the way down the gel, after which the cathode buffer was switched to 50
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mM Bis-Tris, 50 mM Tricine, 0.002% Coomassie brilliant blue G250, pH 6.8. The
gel was run at 30 mA until the dye front reached the bottom of the gel.
The gel was soaked in transfer buffer (25 mM Tris-HCl, 192 mM glycine,
10% methanol, 0.01% SDS) for 20 minutes at 4°C to coat proteins in the gel with
SDS (Montagner et al., 2011). The gel was then transferred to a PVDF
membrane for 90 minutes at 350 mA using a Trans-Blot Mini Electrophoretic
Transfer Cell (Bio-Rad). The membrane was blocked with 5% milk, 50 mM Tris,
150 mM NaCl, 0.1% Tween 20, pH 7.2 (TBST) overnight. The membrane was
then incubated with double the normal concentration of primary antibody (1:500
anti-PopD or 1:37,500 anti-PopB in 2.5% milk TBST) for one hour on a shaker
(50 rpm), 23°C. The membrane was then washed three times with TBST and
incubated on a shaker as before. A 1:30,000 dilution of secondary antibody (antirabbit conjugated to alkaline phosphatase) in 2.5% milk TBST was incubated
with the membrane for 1 hour as before. The membrane was washed as before
but with an additional wash in TBS to remove the Tween 20 detergent. ImmunStar AP Substrate (Bio-Rad) was added to the membrane to develop. The
western blot was visualized using a Gel Doc XR+ System (Bio-Rad).
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CHAPTER 5
CONCLUSIONS
5.1 Summary
While P. aeruginosa translocators have been successfully reconstituted in
model membranes (Romano et al., 2011), no studies have been performed to
assess these complexes in relation to those formed during infection. A study of
the reconstituted complexes along with those formed in host cell membranes was
conducted.
Initially the membrane complexes were assessed in relation to the P.
aeruginosa T3S complex protein, monomeric PcrV. It is likely that the oligomeric
form is necessary to interact with the membrane bound translocator complex.
Ideally, interaction with the oligomeric PcrV complex would be assayed, however
PcrV oligomers were not available. The needle contains the PcrV complex and
therefore was considered as an alternative source of PcrV oligomers, however
the needles were difficult to purify. Further interaction studies were performed
with live P. aeruginosa cells. Results from these experiments indicate that P.
aeruginosa interacts more readily with the reconstituted heterocomplex than
homo-oligomers of either translocator, however it is unclear whether this binding
occurs through the T3S apparatus. From these studies, it is not clear whether the
heterocomplex reconstituted in model membranes is functional for interaction
with other components of the T3S system.
The translocon formed during infection was isolated. RBCs were
successfully infected by induced contact with P. aeruginosa. The RBC
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membranes were dissolved with detergent, and the translocator complexes were
solubilized. While the size of the translocon isolated from RBC membranes could
not be estimated, appropriate conditions for forming the translocons on RBCs,
and appropriate conditions for solubilizing the translocon from RBC membranes
were assessed.
5.2 Future directions
5.2.1 Does P. aeruginosa bind specifically to heterocomplexes
reconstituted in model membranes?
While it is clear that P. aeruginosa binds more readily to the
heterocomplex, it is unclear whether the binding of P. aeruginosa to PopB and
PopD homo-oligomers or heterocomplexes in model membranes is specific.
Further experimentation comparing binding to different amounts of the
heterocomplex and different amounts of both homo-oligomers, would help
determine if homo-oligomer binding is specific. Furthermore, reconstituting other
irrelevant membrane proteins in the membranes would determine if P.
aeruginosa binds nonspecifically to protein on membranes.
5.2.2 Does P. aeruginosa binding to heterocomplexes reconstituted in
model membranes occur through the T3S apparatus?
To confirm interactions are specific to the T3S apparatus, the experiment
described in 3.2.3 must be repeated with a PAKΩPopD strain in place of PAK.
This would allow for the comparison of binding between cells that do not produce
the T3S apparatus, and those that do, without secreting additional translocators
that affect binding to liposomes. Furthermore, this experiment should also include
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a sample containing only PopB homo-oligomers. This would allow for comparison
to binding with the heterocomplex, since homo-oligomers are present when
forming the heterocomplex (Romano et al., submitted).
5.2.3 Utilizing a P. aeruginosa mutant that does not secrete
phospholipases
P. aeruginosa secretes effector proteins through the T3S system. These
effectors are translocated through the translocon pore into the host cell. One of
the effectors (ExoU) functions as a phospholipase (Sato and Frank, 2004). It is
possible that this effector is secreted, degrading the liposomes. If a specific
interaction occurred between the cell and the heterocomplex, this could stimulate
secretion of this component. It is also possible that induction of T3S by low
calcium could stimulate secretion of this phospholipase. By not stimulating T3S,
secretion of this phospholipase would be minimized, however fewer T3S
apparatuses will be produced (Mueller et al., 2005). To overcome this, a mutant
strain that does not produce this effector could be used for this experiment.
5.2.4 Isolate the translocon from infected epithelial cells
Translocators have been detected on epithelial cells following infection
with P. aeruginosa (Y. Tang, unpublished data). Since epithelial cells are the
targets of P. aeruginosa infections in humans, it would be interesting to compare
these translocons to those isolated from RBCs. The translocon could be isolated
from the cell membranes using methods similar to those used for isolation from
RBCs. Less translocons will be obtained, as infections cannot be performed
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easily with a large amount of epithelial cells as can be done with RBCs. To
overcome this, the translocons could be purified as described below.
5.2.4.1 Purification of the translocon from membranes
After solubilizing the membranes, the translocon could be isolated from
other solubilized membrane proteins using chromatography. It is possible to add
a tag to isolate the translocon from other complexes efficiently (Montagner et al.,
2011). This would allow for translocons to be concentrated, allowing the
translocon to be more easily analyzed by BN-PAGE.

66

REFERENCES
Akeda, Y., & Galán, J. E. (2005). Chaperone release and unfolding of substrates
in type III secretion. Nature, 437(7060), 911–915.
Blaylock, B., Berube, B. J., & Schneewind, O. (2010). YopR impacts type III
needle polymerization in Yersinia species. Molecular Microbiology, 75(1),
Broz, P., Mueller, C. a., Müller, S. a., Philippsen, A., Sorg, I., Engel, A., &
Cornelis, G. R. (2007). Function and molecular architecture of the Yersinia
injectisome tip complex. Molecular Microbiology, 65(5), 1311–1320.
Bucki, R., Pastore, J. J., Randhawa, P., Vegners, R., Weiner, D. J., & Janmey, P.
A. (2004). Antibacterial Activities of Rhodamine B-Conjugated GelsolinDerived Peptides Compared to Those of the Antimicrobial Peptides
Cathelicidin LL37, Magainin II, and Melittin. Antimicrobial Agents and
Chemotherapy, 48(5), 1526–1533.
Carmeli, Y., Troillet, N., Eliopoulos, G. M., & Samore, M. H. (1999). Emergence
of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks
associated with different antipseudomonal agents. Antimicrobial Agents and
Chemotherapy, 43(6), 1379–1382.
Chevallet, M., Luche, S., & Rabilloud, T. (2006). Silver staining of proteins in
polyacrylamide gels. Nature Protocols, 1(4), 1852–1858.
Chicurel, M. (2000). Slimebusters. Nature, 408(6810), 284–286. Retrieved from
Coburn, B., Sekirov, I., & Finlay, B. B. (2007). Type III secretion systems and
disease. Clinical Microbiology Reviews, 20(4), 535–549.
Cogen, A. L., Nizet, V., & Gallo, R. L. (2008). Skin microbiota: A source of
disease or defence? British Journal of Dermatology, 158(3), 442–455.
Cordes, F. S., Komoriya, K., Larquet, E., Yang, S., Egelman, E. H., Blocker, A., &
Lea, S. M. (2003). Helical structure of the needle of the type III secretion
system of Shigella flexneri. Journal of Biological Chemistry, 278(19), 17103–
17107.
Cornelis, G. R. (2006). The type III secretion injectisome. Nature Reviews.
Microbiology, 4(11), 811–825.
Cornelis, G., Vanootegem, J.-C., & Sluiters, C. (1987). Transcription of the yop
regulon from Y. enterocolitica requires trans acting pYV and chromosomal
genes. Microbial Pathogenesis, 2(5), 367–379.

67

Cymer, F., von Heijne, G., & White, S. H. (2014). Mechanisms of Integral
Membrane Protein Insertion and Folding. Journal of Molecular Biology,
427(5), 999–1022.
Dacheux, D., Goure, J., Chabert, J., Usson, Y., & Attree, I. (2001). Pore-forming
activity of type III system-secreted proteins leads to oncosis of
Pseudomonas aeruginosa-infected macrophages. Molecular Microbiology,
40(1), 76–85.
Deng, Q., Zhang, Y., & Barbieri, J. T. (2007). Intracellular trafficking of
Pseudomonas ExoS, a type III cytotoxin. Traffic, 8(10), 1331–1345.
Dickenson, N. E., Choudhari, S. P., Adam, P. R., Kramer, R. M., Joshi, S. B.,
Middaugh, C. R., … Picking, W. D. (2013). Oligomeric states of the Shigella
translocator protein IpaB provide structural insights into formation of the type
III secretion translocon. Protein Science, 22(5), 614–627.
Drulis-Kawa, Z., & Dorotkiewicz-Jach, A. (2010). Liposomes as delivery systems
for antibiotics. International Journal of Pharmaceutics, 387(1-2), 187–98.
Espina, M., Olive, A. J., Kenjale, R., Moore, D. S., Ausar, S. F., Kaminski, R. W.,
… Picking, W. L. (2006). IpaD localizes to the tip of the type III secretion
system needle of Shigella flexneri. Infection and Immunity, 74(8), 4391–
4400.
Fiala, G. J., Schamel, W. W. a, & Blumenthal, B. (2011). Blue native
polyacrylamide gel electrophoresis (BN-PAGE) for analysis of multiprotein
complexes from cellular lysates. Journal of Visualized Experiments : JoVE,
(48), 1–8.
Filloux, A., & Vallet, I. (2003). Biofilm: Mise en place et organisation d’une
communauté bactérienne. Medecine/Sciences, 19(1), 77–83.
Gebus, C. (2008). Interactome des antigènes protecteurs V de Pseudomonas
aeruginosa et de Yersinia pestis : Mécanisme d'assemblage et interaction
avec l'aiguille de sécrétion de type III. Université Joseph-Fourier-Grenoble.
tel-00335165.
Goure, J., Broz, P., Attree, O., Cornelis, G. R., & Attree, I. (2005). Protective antiV antibodies inhibit Pseudomonas and Yersinia translocon assembly within
host membranes. The Journal of Infectious Diseases, 192(2), 218–225.

68

Goure, J, A Pastor, E Faudry, J Chabert, A Dessen, & I Attree. (2004) The V
antigen of Pseudomonas aeruginosa is required for assembly of the
functional PopB/PopD translocation pore in host cell membranes. Infect.
Immun. 72, 4741−4750.Hauser, A. R., Fleiszig, S., Kang, P. J., Mostov, K., &
Engel, J. N. (1998). Defects in Type III Secretion Correlate with
Internalization of Pseudomonas aeruginosa by Epithelial Cells. Infect.
Immun., 66(4), 1413–1420.
Hoiczyk, E., & Blobel, G. (2001). Polymerization of a single protein of the
pathogen Yersinia enterocolitica into needles punctures eukaryotic cells.
Proc. Natl. Acad. Sci. U.S.A., 98 (8 ), 4669–4674.
Hoyle, B. D., & Costerton, J. W. (1991). Bacterial resistance to antibiotics: the
role of biofilms. Progress in Drug Research, 37, 91–105.
Hume, P. J., McGhie, E. J., Hayward, R. D., & Koronakis, V. (2003). The purified
Shigella IpaB and Salmonella SipB translocators share biochemical
properties and membrane topology. Molecular Microbiology, 49(2), 425–439.
Jessen, D. L., Osei-Owusu, P., Toosky, M., Roughead, W., Bradley, D. S., &
Nilles, M. L. (2014). Type III secretion needle proteins induce cell signaling
and cytokine secretion via toll-like receptors. Infection and Immunity, 82(6),
2300–2309.
Journet, L., Agrain, C., Broz, P., & Cornelis, G. R. (2003). The Needle Length of
Bacterial Injectisomes Is Determined by a Molecular Ruler. Science,
302(5651), 1757–1760.
Kenjale, R., Wilson, J., Zenk, S. F., Saurya, S., Picking, W. L., Picking, W. D., &
Blocker, A. (2005). The needle component of the type III secreton of Shigella
regulates the activity of the secretion apparatus. Journal of Biological
Chemistry, 280(52), 42929–42937.
Lee, V. T., Smith, R. S., Tu, B., & Lory, S. (2005). Activities of Pseudomonas
aeruginosa Effectors Secreted by the Type III Secretion System In Vitro and
during Infection. Infect Immun, 73(3), 1695–1705.
Lichtenberg, D., Ahyayauch, H., & Goñi, F. M. (2013). The mechanism of
detergent solubilization of lipid bilayers. Biophysical Journal, 105(2), 289–
299.
Linke, D. (2009). Chapter 34 Detergents. An Overview. Methods in Enzymology
(1st ed., Vol. 463). Elsevier Inc.

69

Liu, P. V, & Hsieh, H. (1973). Exotoxins of Pseudomonas aeruginosa. III.
Characteristics of Antitoxin A. Journal of Infectious Diseases , 128 (4 ), 520–
526.
Luisi, Z. and, Müller, R. H., & Peters, K. (1998). Nanosuspensions for the
formulation of poorly soluble drugs: Binding of Positively Charged
Liposomes to Bacteria. International Journal of Pharmaceutics.
Lyczak, J B, C L Cannon, & J B Pier. (2000) Establishment of Pseudomonas
aeruginosa infection: lessons fom a versatile opportunist. Microbes Infect., 2,
1051-1060.
Matteï, P.-J., Faudry, E., Job, V., Izoré, T., Attree, I., & Dessen, A. (2011).
Membrane targeting and pore formation by the type III secretion system
translocon. The FEBS Journal, 278(3), 414–426.
Monopoli, K. (2014). Characterization of the Pseudomonas aeruginosa Type III
Secretion Translocon in Model Membranes, University of Massachusetts
Amherst Commonwealth Honors College Theses and Projects.
Montagner, C., Arquint, C., & Cornelis, G. R. (2011). Translocators YopB and
YopD from yersinia enterocolitica form a multimeric integral membrane
complex in eukaryotic cell membranes. Journal of Bacteriology, 193(24),
6923–6928.
Montie, T. C., Craven, R. C., & Holder, I. a. (1982). Flagellar preparations from
Pseudomonas aeruginosa: Isolation and characterization. Infection and
Immunity, 35(1), 281–288.
Mounier, J., Popoff, M. R., Enninga, J., Frame, M. C., Sansonetti, P. J., & Van
Nhieu, G. T. (2009). The IpaC carboxyterminal effector domain mediates
Src-dependent actin polymerization during Shigella invasion of epithelial
cells. PLoS Pathogens, 5(1).
Mueller, C. a, Broz, P., Müller, S. a, Ringler, P., Erne-Brand, F., Sorg, I., …
Cornelis, G. R. (2005). The V-antigen of Yersinia forms a distinct structure at
the tip of injectisome needles. Science, 310(5748), 674–676.
Olive, A. J., Kenjale, R., Espina, M., Moore, D. S., Picking, W. L., & Picking, W.
D. (2007). Bile salts stimulate recruitment of IpaB to the Shigella flexneri
surface, where it colocalizes with IpaD at the tip of the type III secretion
needle. Infection and Immunity, 75(5), 2626–2629.

70

Osiecki, J. C., Barker, J., Picking, W. L., Serfis, A. B., Berring, E., Shah, S., …
Picking, W. D. (2001). IpaC from Shigella and SipC from Salmonella
possess similar biochemical properties but are functionally distinct.
Molecular Microbiology, 42(2), 469–481.
Pastor, A., Chabert, J., Louwagie, M., Garin, J., & Attree, I. (2005). PscF is a
major component of the Pseudomonas aeruginosa type III secretion needle.
FEMS Microbiology Letters, 253(1), 95–101.
Pettersson, J., Nordfelth, R., Dubinina, E., Bergman, T., Gustafsson, M.,
Magnusson, K. E., & Wolf-Watz, H. (1996). Modulation of Virulence Factor
Expression by Pathogen Target Cell Contact. Science, 273 (5279 ), 1231–
1233.
Raybourne, R. B., & Bunning, V. K. (1994). Bacterium-host cell interactions at the
cellular level: Fluorescent labeling of bacteria and analysis of short-term
bacterium-phagocyte interaction by flow cytometry. Infection and Immunity,
62(2), 665–672.
Romano, F. B., Rossi, K. C., Savva, C. G., Holzenburg, A., Clerico, E. M., &
Heuck, A. P. (2011). Efficient isolation of pseudomonas aeruginosa type III
secretion translocators and assembly of heteromeric transmembrane pores
in model membranes. Biochemistry, 50(33), 7117–7131.
Romano, F. B., Rossi, K. C., Tang, Y., Monopoli, K. R., & Ross, J. L. (n.d.). Type
3 Secretion translocators spontaneously assemble a hexadecameric
transmembrane complex. Journal of Biological Chemistry, submitted.
Sato, H., & Frank, D. W. (2004). ExoU is a potent intracellular phospholipase.
Molecular Microbiology, 53(5), 1279-1290.
Schägger, H., Cramer, W. a, & von Jagow, G. (1994). Analysis of molecular
masses and oligomeric states of protein complexes by blue native
electrophoresis and isolation of membrane protein complexes by twodimensional native electrophoresis. Anal. Biochem., 217, 220–230.
Schraidt, O., & Marlovits, T. C. (2011). Three-dimensional model of Salmonella’s
needle complex at subnanometer resolution. Science (New York, N.Y.),
331(6021), 1192–1195
Sundin, C., Thelaus, J., Bröms, J. E., & Forsberg, Å. (2004). Polarisation of type
III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and
PopN. Microbial Pathogenesis, 37(6), 313–322.

71

Tamano, K., Aizawa, S., Katayama, E., Nonaka, T., Imajoh-Ohmi, S., Kuwae, a,
… Sasakawa, C. (2000). Supramolecular structure of the Shigella type III
secretion machinery: the needle part is changeable in length and essential
for delivery of effectors. The EMBO Journal, 19(15), 3876–3887.
Tardy, F., Homblé, F., Neyt, C., Wattiez, R., Cornelis, G. R., Ruysschaert, J. M.,
& Cabiaux, V. (1999). Yersinia enterocolitica type III secretion-translocation
system: channel formation by secreted Yops. The EMBO Journal, 18(23),
6793–6799.
Tenover, F. C. (2006). Mechanisms of Antimicrobial Resistance in Bacteria.
American Journal of Medicine, 119(6 SUPPL. 1).
Toussaint, B., Delic-Attree, I., & Vignais, P. M. (1993). Pseudomonas aeruginosa
contains an IHF-like protein that binds to the algD promoter. Biochemical
and Biophysical Research Communications, 196(1), 416–421.
Vincent, J. L. (2003). Nosocomial infections in adult intensive-care units. Lancet,
361(9374), 2068-2077.
Wittig, I., Braun, H.-P., & Schägger, H. (2006). Blue native PAGE. Nature
Protocols, 1(1), 418–428.
Zhang, Y., Deng, Q., & Barbieri, J. T. (2007). Intracellular localization of type IIIdelivered Pseudomonas ExoS with endosome vesicles. Journal of Biological
Chemistry, 282(17), 13022–13032.

72

